Navigation Links
Study Suggests Way to 'Mop Up' Leukemia Cells
Date:1/8/2010

Vaccine beats back cancer left behind after treatment, researchers say,,,,

FRIDAY, Jan. 8 (HealthDay News) -- Preliminary research suggests that a vaccine could help reduce the risk of a relapse in some people who take the drug Gleevec to treat chronic myeloid leukemia.

"Should this vaccine approach prove to be successful, the ability to get patients off lifelong Gleevec therapy would be a significant advance," Dr. Hyam Levitsky, a professor of oncology, medicine and urology at the Johns Hopkins Kimmel Cancer Center in Baltimore, said in a news release from the center.

Imatinib mesylate (Gleevec) treats chronic myeloid leukemia, but can leave some cancerous cells behind. They can cause a relapse.

Researchers from the cancer center tested a vaccine on 19 people who had cancerous cells even though they'd taken Gleevec for a year. After about 72 months, the number of cancer cells had declined in 13 people. In seven, the cancer had vanished. Reported side effects of the treatment were relatively rare.

But it's not clear if the results were actually caused by the vaccine, the researchers said, because of the small number of participants and the lack of comparison with other treatments.

"We want to get rid of every last cancer cell in the body," Levitsky said, "and using cancer vaccines may be a good way to mop up residual disease."

The vaccine was made from cancer cells that were blasted with radiation to stop them from being cancerous, the researchers said.

The research, funded by the U.S. National Institutes of Health, was published in the Jan. 1 issue of Clinical Cancer Research.

More information

The U.S. National Cancer Institute has more on Gleevec.



-- Randy Dotinga



SOURCE: Johns Hopkins Kimmel Cancer Center, news release, Jan. 6, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Periodic Paralysis Study Reveals Gene Causing Disorder
2. UCLA study shows metformin is safe for patients with advanced heart failure and diabetes mellitus
3. Technology new gateway into treatment for problem alcohol users: Study
4. Few breast cancer surgeons follow quality of care standards, U-M study finds
5. Study shows serious emotional disturbances among children after Katrina
6. Study links restless leg syndrome with erectile dysfunction in older men
7. Study identifies those elderly most at risk for major depression
8. Despite Earlier Doubts, Feinstein Study Shows Fetal Transplants May Benefit Parkinson's Patients Over Age 60
9. New Study Shows That American Public is Willing to Accept Major Reforms in Medicare Program
10. Herbal Science Organization Clarifies New Ginkgo Study
11. CRN Responds to Ginkgo Biloba Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: